title: Levodopa-induced hyperhomocysteinaemia in Parkinson's disease.
authors.forename: K
authors.initials: K
authors.lastname: Yasui
authors.forename: K
authors.initials: K
authors.lastname: Nakaso
authors.forename: H
authors.initials: H
authors.lastname: Kowa
authors.forename: T
authors.initials: T
authors.lastname: Takeshima
authors.forename: K
authors.initials: K
authors.lastname: Nakashima
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D006710:Homocysteine / Q000097:blood / Q000187:drug effects; D006801:Humans; D020138:Hyperhomocysteinemia / Q000097:blood / Q000139:chemically induced* / Q000235:genetics; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000097:blood / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000978:Antiparkinson Agents; D006710:Homocysteine; D007980:Levodopa